eMocha CEO Sebastian Seiguer joins us to look ahead at the Biden administration and discuss what needs to happen next for telehealth. Powered by WPeMatico
As would-be vaccine recipients scramble for appointment time slots, in too many cases “the technology is just being used wrong,” says one exec. Powered by WPeMatico
The strategy includes a proposed executive order that will direct federal agencies to ramp up collection, sharing and analysis of data to “support an equitable COVID-19 response and recovery.” Powered by WPeMatico
The changes herald a major overhaul for agencies struggling to respond to the COVID-19 crisis. Powered by WPeMatico
It helped eliminate delays for mission-critical applications, improve clinician experience, optimize IT human resources, make disk expansion process 10X faster and reduce time spent managing storage by 75%. Powered by WPeMatico
As National Coordinator for Health IT, the interoperability veteran will bring deep standards expertise as the rubber hits the road on nationwide API-based data exchange. Powered by WPeMatico
“Director-General Dr. Tedros, distinguished representatives, friends and colleagues: It is an honor for me to be here, representing the United States of America Powered by WPeMatico
Vaccines by six developers – Sinopharm, Sinovac, Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, and Sputnik V (Gamaleya Research Institute) – are the ones doing the rounds in the region. Here’s what’s known about them. Powered by WPeMatico
There are four main types of vaccines currently approved, in approval or in trial in the MENA region in its fight against COVID-19. We bring you a summary of just what they are, how they differ, along with the advantages and disadvantages of each type. Powered by WPeMatico
The center operates on a 24 x 7 basis, and patients can either call in, email or reach out through social media platforms. Powered by WPeMatico